|
Evaluation of acute and chronic endpoints, including survival/mortality,
immobilisation and bioluminescence
Assessment of the reproducibility/repeatability and sensitivity of the proposed
microbiotests
Cost-benefit assessment in comparison to the standard test protocols
Intercalibration exercise, between partners, for one of two bioassays
|